Introduction: Management of congestive heart failure is a serious public health problem. The use of implantable hemodynamic monitors (IHMs) may assist in this management by providing continuous ...
While it has been suggested that targeting hemodynamics for improvement can, in fact, improve outcome in patients with decompensated advanced heart failure, further studies will refine the role of ...
WASHINGTON, DC—For patients who present with STEMI complicated by cardiogenic shock (STEMI-CS), it’s not news that the long-awaited DanGer Shock trial showed better 180-day survival after Impella CP ...
Relief Cardiovascular, Inc., a private medical device company developing intelligent device-based therapy solutions for heart failure (HF) congestion, today announced positive 90-day results from the ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Hemodynamic instability and myocardial dysfunction are major factors preventing the transplantation of hearts from organ donors after brain death. Intravenous levothyroxine is widely used in donor ...
KDIGO global report reveals the strong link between heart failure and chronic kidney disease, stressing early diagnosis, ...
Researchers have found in a new research that Canagliflozin may have therapeutic potential for patients with heart failure related to cardiac surgery. However, larger multicenter ...